Details for Patent: 10,537,572
✉ Email this page to a colleague
Which drugs does patent 10,537,572 protect, and when does it expire?
Patent 10,537,572 protects ORILISSA and is included in one NDA.
This patent has six patent family members in five countries.
Summary for Patent: 10,537,572
Title: | Methods of administering elagolix |
Abstract: | The present disclosure relates to the use of GnRH receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole. |
Inventor(s): | Goss; Sandra L. (Wadsworth, IL), Klein; Cheri E. (Northbrook, IL), Ng; Juki Wing-Keung (Highland Park, IL), Salem; Ahmed (Libertyville, IL) |
Assignee: | AbbVie Inc. (North Chicago, IL) |
Application Number: | 15/957,469 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,537,572 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,537,572
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | ORILISSA | elagolix sodium | TABLET;ORAL | 210450-001 | Jul 23, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | MANAGEMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS USING 150MG ELAGOLIX WHILE CO-ADMINISTERING RIFAMPIN | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,537,572
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016317955 | ⤷ Try a Trial | |||
Australia | 2021204104 | ⤷ Try a Trial | |||
Canada | 3002791 | ⤷ Try a Trial | |||
European Patent Office | 3344245 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |